Follow
Lucia Trilla-Fuertes
Lucia Trilla-Fuertes
Hospital Universitario La Paz-IdiPAZ
Verified email at salud.madrid.org - Homepage
Title
Cited by
Cited by
Year
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
G Prado-Vázquez, A Gámez-Pozo, L Trilla-Fuertes, JM Arevalillo, ...
Scientific reports 9 (1), 1538, 2019
732019
Functional proteomics outlines the complexity of breast cancer molecular subtypes
A Gámez-Pozo, L Trilla-Fuertes, J Berges-Soria, N Selevsek, ...
Scientific Reports 7 (1), 10100, 2017
532017
Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics
A Gámez-Pozo, L Trilla-Fuertes, G Prado-Vázquez, C Chiva, ...
PLoS One 12 (6), e0178296, 2017
302017
Molecular characterization of breast cancer cell response to metabolic drugs
L Trilla-Fuertes, A Gámez-Pozo, JM Arevalillo, M Díaz-Almirón, ...
Oncotarget 9 (11), 9645, 2018
222018
Urothelial cancer proteomics provides both prognostic and functional information
G de Velasco, L Trilla-Fuertes, A Gamez-Pozo, M Urbanowicz, ...
Scientific Reports 7 (1), 15819, 2017
212017
Isotopologue multipoint calibration for proteomics biomarker quantification in clinical practice
C Chiva, O Pastor, L Trilla-Fuertes, A Gámez-Pozo, JA Fresno Vara, ...
Analytical chemistry 91 (8), 4934-4938, 2019
202019
Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities
L Trilla-Fuertes, A Gámez-Pozo, G Prado-Vázquez, A Zapater-Moros, ...
BMC cancer 19, 1-9, 2019
192019
Immune expression profile identification in a group of proliferative verrucous leukoplakia patients: A pre-cancer niche for oral squamous cell carcinoma development
C Llorens, B Soriano, L Trilla-Fuertes, L Bagan, R Ramos-Ruiz, ...
Clinical Oral Investigations 25, 2645-2657, 2021
152021
Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer
L Trilla-Fuertes, A Gámez-Pozo, E López-Camacho, G Prado-Vázquez, ...
BMC cancer 20, 1-11, 2020
142020
Melanoma proteomics suggests functional differences related to mutational status
L Trilla-Fuertes, A Gámez-Pozo, G Prado-Vázquez, A Zapater-Moros, ...
Scientific reports 9 (1), 7217, 2019
122019
Comprehensive characterization of the mutational landscape in localized anal squamous cell carcinoma
L Trilla-Fuertes, I Ghanem, J Maurel, G Laura, M Mendiola, C Peńa, ...
Translational Oncology 13 (7), 100778, 2020
112020
Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer
A Zapater-Moros, A Gámez-Pozo, G Prado-Vázquez, L Trilla-Fuertes, ...
Oncotarget 9 (45), 27586, 2018
102018
Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer
K Rojas, L Trilla-Fuertes, A Gámez-Pozo, C Chiva, J Sepúlveda, L Manso, ...
ecancermedicalscience 13, 2019
92019
miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma
L Trilla-Fuertes, N Miranda, D Castellano, R López-Vacas, ...
PloS one 15 (2), e0229075, 2020
72020
Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancer
E López-Camacho, L Trilla-Fuertes, A Gámez-Pozo, I Dapía, ...
Biomedicine & Pharmacotherapy 149, 112844, 2022
62022
Bayesian networks established functional differences between breast cancer subtypes
L Trilla-Fuertes, A Gámez-Pozo, JM Arevalillo, R López-Vacas, ...
PloS one 15 (6), e0234752, 2020
62020
Computational metabolism modeling predicts risk of distant relapse-free survival in breast cancer patients
L Trilla-Fuertes, A Gámez-Pozo, M Díaz-Almirón, G Prado-Vázquez, ...
Future Oncology 15 (30), 3483-3490, 2019
52019
MiRNAs in renal cell carcinoma
J Miranda-Poma, L Trilla-Fuertes, E López-Camacho, A Zapater-Moros, ...
Clinical and Translational Oncology 24 (11), 2055-2063, 2022
42022
Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab
L Trilla-Fuertes, A Gámez-Pozo, J Maurel, R Garcia-Carbonero, ...
Scientific reports 11 (1), 7402, 2021
42021
Genetic profile and functional proteomics of anal squamous cell carcinoma: Proposal for a molecular classification
L Trilla-Fuertes, I Ghanem, A Gamez-Pozo, J Maurel, G Laura, ...
Molecular & Cellular Proteomics 19 (4), 690-700, 2020
42020
The system can't perform the operation now. Try again later.
Articles 1–20